Recent Quotes (30 days)

You have no recent quotes
chg | %

Novadaq Technologies Inc.  

(Public, TSE:NDQ)   Watch this stock  
Find more results for NDQ
+0.66 (4.70%)
Oct 8 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 14.70 - 15.30
52 week 11.68 - 21.50
Open 15.30
Vol / Avg. 2,100.00/1,156.00
Mkt cap 826.08M
P/E     -
Div/yield     -
EPS -0.90
Shares 56.20M
Beta 0.21
Inst. own     -
Nov 16, 2015
Novadaq Technologies Inc Analyst & Investor Day - 9:00AM EST - Add to calendar
Nov 4, 2015
Q3 2015 Novadaq Technologies Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Sep 17, 2015
Novadaq Technologies Inc at Morgan Stanley Healthcare Conference
Aug 12, 2015
Novadaq Technologies Inc at Canaccord Genuity Growth Conference
Jul 28, 2015
Q2 2015 Novadaq Technologies Inc Earnings Call
Jul 28, 2015
Q2 2015 Novadaq Technologies Inc Earnings Release

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -40.00% -52.26%
Operating margin -82.27% -48.75%
EBITD margin - -36.50%
Return on average assets -12.91% -11.90%
Return on average equity -15.47% -14.43%
Employees 56 -
CDP Score - -


5090 Explorer Dr Suite 202
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links


Novadaq Technologies Inc. develops and commercializes medical imaging and therapeutic devices for use in the operating room. The Company's imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. The Company generates revenues from the sale of medical devices and consumables, capital devices or consumable products, the rental of capital devices, royalties, upfront payments received from partners for exclusive sales and marketing rights, and extended warranty services agreements in connection with capital sales. The Company’s SPY imaging products are SPY Elite, FIREFLY, LUNA, PINPOINT, CO2 HEART LASER systems and DermACELL Advanced Decellularized Dermis. The SPY Imaging System is United States Food and Drug Administration (FDA) cleared for use in seven surgical specialties, including coronary artery bypass, cardiovascular, plastic, reconstructive, micro, organ transplant and gastrointestinal surgery.

Officers and directors

Arun Menawat Ph.D. President, Chief Executive Officer, Director
Roger Deck Chief Financial Officer
Anthony F. Griffiths Independent Non-Executive Chairman of the Board
Patrice E. Merrin Director
Age: 66
Robert S. White Director
Aaron Davidson Independent Director
Age: 46
Harold O. Koch Jr. Independent Director
Age: 59